Angiology: Open Access
Open Access

Department of Medicine, Gansu Provincial Hospital, Lanzhou, Gansu Province, China

Publications

• Research Article   
  Riociguat for the Treatment of Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Author(s): Linlin Dang, Yurong Zhang, Xiaoli Mou, Tingting Shu, Min Cao and Ai-Ai Chu*
  
  Background: The treatment of Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Arterial Hypertension (CTEPH) with riociguat is approved and can significantly improve patients' exercise tolerance, hemodynamic parameters, cardiac function, etc. However, for pulmonary arterial hypertension caused by other reasons, the therapeutic effect of riociguat needs further verification. The purpose of this article is to evaluate the therapeutic effect of riociguat on patients with pulmonary arterial hypertension. Method: A computer was used to conduct literature search on commonly used databases, including EMbase, PubMed, Web of Science, and Cochrane Library, to collect clinical studies related to riociguat and pulmonary arterial hypertension. The search was conducted from database establishment to November 16, 2023 using Rev.. View More»
  DOI: 10.35841/2329-9495.24.12.516

  Abstract HTML PDF